<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Beactica AB</title>
	<atom:link href="http://www.beactica.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.beactica.com</link>
	<description>High-Quality Fragment Leads</description>
	<lastBuildDate>Thu, 25 Feb 2010 11:43:29 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Dr Gisela Sitbon joins the Board of Beactica</title>
		<link>http://www.beactica.com/2010/02/dr-gisela-sitbon-joins-the-board-of-beactica/</link>
		<comments>http://www.beactica.com/2010/02/dr-gisela-sitbon-joins-the-board-of-beactica/#comments</comments>
		<pubDate>Wed, 03 Feb 2010 08:30:38 +0000</pubDate>
		<dc:creator>perkal</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/?p=339</guid>
		<description><![CDATA[Beactica, the leading Swedish fragment-based drug discovery company, today announced the appointment of Dr Gisela Sitbon to its Board. Dr Sitbon, Deputy Region Director at Innovationsbron AB, brings more than 25 years experience from the life science industry within the areas of business development, R&#38;D management and quality assurance to the Company.
“We are delighted to [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2010/02/dr-gisela-sitbon-joins-the-board-of-beactica/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica welcomes Innovationsbron as a new shareholder</title>
		<link>http://www.beactica.com/2010/01/beactica-welcomes-innovationsbron-as-a-new-shareholder/</link>
		<comments>http://www.beactica.com/2010/01/beactica-welcomes-innovationsbron-as-a-new-shareholder/#comments</comments>
		<pubDate>Fri, 29 Jan 2010 07:01:36 +0000</pubDate>
		<dc:creator>perkal</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/?p=328</guid>
		<description><![CDATA[Beactica AB, the leading Swedish fragment-based drug discovery company, today announced a new investment and the addition of Innovationsbron AB to its shareholders. They join Uppsala University Holding Company and the founders as continuing investors. The funds will be used to finance the progression of Beactica’s internal drug discovery pipeline.
“We are delighted to welcome Innovationsbron [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2010/01/beactica-welcomes-innovationsbron-as-a-new-shareholder/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Professor Bo Öberg joins the Board of Beactica</title>
		<link>http://www.beactica.com/2010/01/professor-bo-oberg-joins-the-board-of-beactica/</link>
		<comments>http://www.beactica.com/2010/01/professor-bo-oberg-joins-the-board-of-beactica/#comments</comments>
		<pubDate>Wed, 13 Jan 2010 06:00:46 +0000</pubDate>
		<dc:creator>perkal</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/?p=264</guid>
		<description><![CDATA[Beactica, the leading Swedish fragment-based drug discovery company, today announced the appointment of Professor Bo Öberg to its Board. Professor Öberg, CEO of Medivir HIV Franchise AB, brings almost 40 years of pharmaceutical industry experience as a senior executive and board member in both biotechnology and pharmaceutical companies.
“We are very pleased that Bo Öberg has [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2010/01/professor-bo-oberg-joins-the-board-of-beactica/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica announces its participation in a Marie Curie Initial Training Network</title>
		<link>http://www.beactica.com/2009/11/beactica-announces-its-participation-in-a-marie-curie-initial-training-network/</link>
		<comments>http://www.beactica.com/2009/11/beactica-announces-its-participation-in-a-marie-curie-initial-training-network/#comments</comments>
		<pubDate>Fri, 27 Nov 2009 07:00:47 +0000</pubDate>
		<dc:creator>perkal</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/?p=221</guid>
		<description><![CDATA[Beactica, the Swedish fragment-based drug discovery company, today announced its participation in a Marie Curie Initial Training Network (ITN). The ITN, called BrainTrain, is funded through the 7th EU Framework Programme and aims to deliver 15 skilled early stage researchers in the field of neuroscience. The network is composed of eight leading EU institutes (Amsterdam, [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2009/11/beactica-announces-its-participation-in-a-marie-curie-initial-training-network/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica announces drug discovery agreement with Cubist Pharmaceuticals</title>
		<link>http://www.beactica.com/2009/05/beactica-announces-drug-discovery-agreement-with-cubist-pharmaceuticals/</link>
		<comments>http://www.beactica.com/2009/05/beactica-announces-drug-discovery-agreement-with-cubist-pharmaceuticals/#comments</comments>
		<pubDate>Tue, 26 May 2009 07:00:15 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=25</guid>
		<description><![CDATA[Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc. (Lexington, MA; NASDAQ: CBST). Under the agreement, Beactica will use its Sprint™ surface plasmon resonance (SPR)-integrated drug discovery platform to target multi-component proteins from pathogenic bacteria of interest to Cubist. Financial terms of the [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2009/05/beactica-announces-drug-discovery-agreement-with-cubist-pharmaceuticals/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and Uppsala University</title>
		<link>http://www.beactica.com/2009/01/beactica-announces-fragment-based-drug-discovery-research-collaboration-with-ge-healthcare-and-uppsala-university/</link>
		<comments>http://www.beactica.com/2009/01/beactica-announces-fragment-based-drug-discovery-research-collaboration-with-ge-healthcare-and-uppsala-university/#comments</comments>
		<pubDate>Tue, 13 Jan 2009 07:00:29 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=27</guid>
		<description><![CDATA[Beactica AB, the Swedish fragment-based drug discovery company, today announced a new research collaboration agreement with GE Healthcare (Chalfont St. Giles, UK), the world leading provider of molecular interaction analysis tools, and Uppsala University (Sweden). The collaboration combines Beactica’s unique approach to fragment-based drug discovery and GE Healthcare’s Biacore™ technology with enzymology expertise from Uppsala [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2009/01/beactica-announces-fragment-based-drug-discovery-research-collaboration-with-ge-healthcare-and-uppsala-university/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica welcomes Uppsala University Holding Company as a new shareholder</title>
		<link>http://www.beactica.com/2008/08/beactica-welcomes-uppsala-university-holding-company-as-a-new-shareholder/</link>
		<comments>http://www.beactica.com/2008/08/beactica-welcomes-uppsala-university-holding-company-as-a-new-shareholder/#comments</comments>
		<pubDate>Fri, 15 Aug 2008 08:00:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=112</guid>
		<description><![CDATA[Beactica AB, a fragment-based drug discovery company spun out of Uppsala University, today announced a new investment and the addition of Uppsala University Holding Company to its shareholders. The funding will support Beactica’s growing internal drug discovery pipeline.
“We are very pleased to welcome Uppsala University as a shareholder” said Beactica CEO, Dr Per Källblad. “Uppsala [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2008/08/beactica-welcomes-uppsala-university-holding-company-as-a-new-shareholder/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica announces new fragment-based drug discovery platform together with IOTA Pharmaceuticals.</title>
		<link>http://www.beactica.com/2008/04/beactica-announces-new-fragment-based-drug-discovery-platform-together-with-iota-pharmaceuticals/</link>
		<comments>http://www.beactica.com/2008/04/beactica-announces-new-fragment-based-drug-discovery-platform-together-with-iota-pharmaceuticals/#comments</comments>
		<pubDate>Thu, 24 Apr 2008 08:00:14 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=109</guid>
		<description><![CDATA[Two leading companies in the area of fragment-based drug discovery (FBDD) today announced a new commercial alliance. IOTA Pharmaceuticals Ltd, based in Cambridge, UK, and Beactica AB, based in Uppsala, Sweden, will join forces to deploy a proprietary FBDD-based lead discovery and optimization platform.

The IOTA-Beactica platform couples comprehensive, site-directed FBDD libraries to    [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2008/04/beactica-announces-new-fragment-based-drug-discovery-platform-together-with-iota-pharmaceuticals/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica announces drug discovery collaboration with Arrow Therapeutics</title>
		<link>http://www.beactica.com/2007/11/beactica-announces-drug-discovery-collaboration-with-arrow-therapeutics/</link>
		<comments>http://www.beactica.com/2007/11/beactica-announces-drug-discovery-collaboration-with-arrow-therapeutics/#comments</comments>
		<pubDate>Mon, 12 Nov 2007 08:00:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=106</guid>
		<description><![CDATA[Beactica AB announced today that it has entered into a drug discovery collaboration agreement       with Arrow Therapeutics Ltd (London, UK) whereby Beactica will direct its novel characterisation       technology at selected Arrow compounds against a confidential target.
“We are very pleased to be working with [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2007/11/beactica-announces-drug-discovery-collaboration-with-arrow-therapeutics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica expands into new premises</title>
		<link>http://www.beactica.com/2007/11/beactica-expands-into-new-premises/</link>
		<comments>http://www.beactica.com/2007/11/beactica-expands-into-new-premises/#comments</comments>
		<pubDate>Thu, 01 Nov 2007 08:00:17 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=102</guid>
		<description><![CDATA[Beactica, the specialist drug discovery company spun out of Uppsala University in 2006,        announced today that it has moved into new premises at the Uppsala Biomedical Centre.
“The move reflects a growing demand for Beactica’s partnership programme from other drug        discovery companies.“ [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2007/11/beactica-expands-into-new-premises/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica double winner in EU-financed drug discovery projects</title>
		<link>http://www.beactica.com/2007/09/beactica-double-winner-in-eu-financed-drug-discovery-projects/</link>
		<comments>http://www.beactica.com/2007/09/beactica-double-winner-in-eu-financed-drug-discovery-projects/#comments</comments>
		<pubDate>Fri, 14 Sep 2007 08:00:25 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=97</guid>
		<description><![CDATA[Beactica, the specialist drug discovery company spun out of Uppsala University in 2006,        will partner in two separate projects both of which have been selected for major grants        through the 7th EU Framework Programme. In each project Beactica will apply its [...]]]></description>
		<wfw:commentRss>http://www.beactica.com/2007/09/beactica-double-winner-in-eu-financed-drug-discovery-projects/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica receives continued funding from Innovationsbron Uppsala to develop its business.</title>
		<link>http://www.beactica.com/2007/06/beactica-receives-continued-funding-from-innovationsbron-uppsala-to-develop-its-business/</link>
		<comments>http://www.beactica.com/2007/06/beactica-receives-continued-funding-from-innovationsbron-uppsala-to-develop-its-business/#comments</comments>
		<pubDate>Thu, 07 Jun 2007 08:00:54 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=94</guid>
		<description><![CDATA[Beactica receives continued funding from Innovationsbron Uppsala to develop its business.
]]></description>
		<wfw:commentRss>http://www.beactica.com/2007/06/beactica-receives-continued-funding-from-innovationsbron-uppsala-to-develop-its-business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica receives funding from the Swedish Governmental Agency for Innovation Systems (VINNOVA) to establish a European drug discovery project.</title>
		<link>http://www.beactica.com/2007/04/beactica-receives-funding-from-the-swedish-governmental-agency-for-innovation-systems-vinnova-to-establish-a-european-drug-discovery-project/</link>
		<comments>http://www.beactica.com/2007/04/beactica-receives-funding-from-the-swedish-governmental-agency-for-innovation-systems-vinnova-to-establish-a-european-drug-discovery-project/#comments</comments>
		<pubDate>Mon, 02 Apr 2007 08:00:50 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=92</guid>
		<description><![CDATA[Beactica receives funding from the Swedish Governmental Agency for Innovation Systems (VINNOVA) to establish a European drug discovery project.
]]></description>
		<wfw:commentRss>http://www.beactica.com/2007/04/beactica-receives-funding-from-the-swedish-governmental-agency-for-innovation-systems-vinnova-to-establish-a-european-drug-discovery-project/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica receives funding from ALMI Företagspartner to develop its technology platform.</title>
		<link>http://www.beactica.com/2006/11/beactica-receives-funding-from-almi-foretagspartner-to-develop-its-technology-platform/</link>
		<comments>http://www.beactica.com/2006/11/beactica-receives-funding-from-almi-foretagspartner-to-develop-its-technology-platform/#comments</comments>
		<pubDate>Wed, 22 Nov 2006 08:00:20 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=89</guid>
		<description><![CDATA[Beactica receives funding from ALMI Företagspartner to develop its technology platform.
]]></description>
		<wfw:commentRss>http://www.beactica.com/2006/11/beactica-receives-funding-from-almi-foretagspartner-to-develop-its-technology-platform/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica wins business competition organised by the Swedish Governmental Agency for Innovation Systems (VINNOVA) and receives funding.</title>
		<link>http://www.beactica.com/2006/10/beactica-wins-business-competition-organised-by-the-swedish-governmental-agency-for-innovation-systems-vinnova-and-receives-funding/</link>
		<comments>http://www.beactica.com/2006/10/beactica-wins-business-competition-organised-by-the-swedish-governmental-agency-for-innovation-systems-vinnova-and-receives-funding/#comments</comments>
		<pubDate>Sun, 08 Oct 2006 08:00:58 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=86</guid>
		<description><![CDATA[Beactica wins business competition organised by the Swedish Governmental Agency for Innovation Systems (VINNOVA) and receives funding.
]]></description>
		<wfw:commentRss>http://www.beactica.com/2006/10/beactica-wins-business-competition-organised-by-the-swedish-governmental-agency-for-innovation-systems-vinnova-and-receives-funding/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica receives funding from Innovationsbron Uppsala to develop its technology platform.</title>
		<link>http://www.beactica.com/2006/10/beactica-receives-funding-from-innovationsbron-uppsala-to-develop-its-technology-platform/</link>
		<comments>http://www.beactica.com/2006/10/beactica-receives-funding-from-innovationsbron-uppsala-to-develop-its-technology-platform/#comments</comments>
		<pubDate>Thu, 05 Oct 2006 08:00:37 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=84</guid>
		<description><![CDATA[Beactica receives funding from Innovationsbron Uppsala to develop its technology platform.
]]></description>
		<wfw:commentRss>http://www.beactica.com/2006/10/beactica-receives-funding-from-innovationsbron-uppsala-to-develop-its-technology-platform/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica receives funding from Uppsala University Holding Company to develop its technology platform.</title>
		<link>http://www.beactica.com/2006/09/beactica-receives-funding-from-uppsala-university-holding-company-to-develop-its-technology-platform/</link>
		<comments>http://www.beactica.com/2006/09/beactica-receives-funding-from-uppsala-university-holding-company-to-develop-its-technology-platform/#comments</comments>
		<pubDate>Tue, 19 Sep 2006 08:00:26 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=81</guid>
		<description><![CDATA[Beactica receives funding from Uppsala University Holding Company to develop its technology platform.
]]></description>
		<wfw:commentRss>http://www.beactica.com/2006/09/beactica-receives-funding-from-uppsala-university-holding-company-to-develop-its-technology-platform/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Beactica is founded in Uppsala by Dr Per Källblad, previously at Medivir AB, and Professor Helena Danielson at Uppsala University.</title>
		<link>http://www.beactica.com/2006/08/beactica-is-founded-in-uppsala-by-dr-per-kallblad-previously-at-medivir-ab-and-professor-helena-danielson-at-uppsala-university/</link>
		<comments>http://www.beactica.com/2006/08/beactica-is-founded-in-uppsala-by-dr-per-kallblad-previously-at-medivir-ab-and-professor-helena-danielson-at-uppsala-university/#comments</comments>
		<pubDate>Fri, 25 Aug 2006 08:00:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.beactica.com/anna/?p=79</guid>
		<description><![CDATA[Beactica is founded in Uppsala by Dr Per Källblad, previously at Medivir AB, and Professor Helena Danielson at Uppsala University.
]]></description>
		<wfw:commentRss>http://www.beactica.com/2006/08/beactica-is-founded-in-uppsala-by-dr-per-kallblad-previously-at-medivir-ab-and-professor-helena-danielson-at-uppsala-university/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
